Lundbeck steers clear of international generics-trend
A number of international pharmaceutical companies have already opened business units dedicated to the sale of generic medicine. But Danish company Lundbeck refuses to jump on board.
Novartis has the subsidiary Sandoz, and Sanofi, GSK and Pfizer are all increasing their efforts. Many major drug manufacturers are now opening their own so-called copy-divisions; business units made to sell generic versions of the companies’ original products.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
- Adgang til alle låste artikler
- Modtag vores daglige nyhedsbreve
- Fuld adgang til vores app
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler:
Potential Lundbeck rival developing alcohol drug
For abonnenter
.jpg&w=384&q=75){kind=logo}
